VERTEX PHARMACEUTICALS INC / MA Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation of $500.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation · last filed 2026-02-13
- VERTEX PHARMACEUTICALS INC / MA unrecognized tax benefits, decrease resulting from foreign currency translation for fiscal 2024 was $500.00K.
- VERTEX PHARMACEUTICALS INC / MA unrecognized tax benefits, decrease resulting from foreign currency translation for fiscal 2022 was $2.30M.
- VERTEX PHARMACEUTICALS INC / MA unrecognized tax benefits, decrease resulting from foreign currency translation for fiscal 2021 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA unrecognized tax benefits, decrease resulting from foreign currency translation for fiscal 2020 was $0.00.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation 12 month |
|---|---|
| 2024-12-31 | $500.00K 10-K · filed 2026-02-13 |
| 2022-12-31 | $2.30M 10-K · filed 2025-02-13 |
| 2021-12-31 | $0.00 10-K · filed 2024-02-15 |
| 2020-12-31 | $0.00 10-K · filed 2023-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |